CorMedix Inc. (CRMD): Capital Expenditures
$2.26M
Year ended 2025-12-31
+117.6%
3-year compound annual growth
+82.2%
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.26M | n/m | 2026-03-05, From 2025-01-01 |
| 2024-12-31 | $116.0K | -64.6% | 2026-03-05, From 2024-01-01 |
| 2023-12-31 | $327.3K | +49.2% | 2025-03-25, From 2023-01-01 |
| 2022-12-31 | $219.4K | -84.6% | 2024-03-12, From 2022-01-01 |
| 2021-12-31 | $1.43M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | $112.6K | +208.0% | 2022-03-29, From 2020-01-01 |
| 2019-12-31 | $36.6K | -25.2% | 2021-03-30, From 2019-01-01 |
| 2018-12-31 | $48.9K | -67.8% | 2020-03-16, From 2018-01-01 |
| 2017-12-31 | $152.0K | +158.8% | 2019-05-29, From 2017-01-01 |
| 2016-12-31 | $58.7K | +280.2% | 2018-03-19, From 2016-01-01 |
| 2015-12-31 | $15.4K | -39.2% | 2017-03-16, From 2015-01-01 |
| 2014-12-31 | $25.4K | -28.8% | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | $35.7K | n/a | 2015-03-12, From 2013-01-01 |
| 2012-12-31 | $0 | -100.0% | 2014-03-31, From 2012-01-01 |
| 2011-12-31 | $1.6K | -84.3% | 2014-03-04, From 2011-01-01 |
| 2010-12-31 | $10.4K | n/a | 2012-04-26, From 2010-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| CorMedix Inc. (CRMD) | 2025-12-31 | $2.26M | n/m |
| Evolus, Inc. (EOLS) | 2025-12-31 | $3.44M | +133.8% |
| Ironwood Pharmaceuticals Inc (IRWD) | 2025-12-31 | $34.0K | -76.1% |
| MannKind Corp (MNKD) | 2025-12-31 | $4.57M | -52.9% |
| Harrow, Inc. (HROW) | 2025-12-31 | $887.0K | -44.4% |
| Vireo Growth Inc. (VREOF) | 2025-12-31 | $28.32M | +142.2% |
| Ligand Pharmaceuticals Inc (LGND) | 2025-12-31 | $452.0K | -75.2% |
| Arvinas, Inc. (ARVN) | 2025-12-31 | $1.90M | +5.6% |
| Arcutis Biotherapeutics, Inc. (ARQT) | 2025-12-31 | $686.0K | +379.7% |
Compare CRMD, EOLS, IRWD, MNKD side by side · Screen every company in Pharmaceutical Preparations ↗